5101 - 5125 of 7916 Results
Title
Year
- Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum2019OPENTitle: Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat StriatumJournal Name: NeurosciencePublisher: Elsevier BVVol: 409Issue #:Start Page: 169End Page: 179Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuroscience.2019.04.033Best OA location URL: https://doi.org/10.1016/j.neuroscience.2019.04.033Citation Count: 44
-
RESTRICTEDTitle: Phosphoregulation on mitochondria: Integration of cell and organelle responsesJournal Name: CNS Neuroscience & TherapeuticsPublisher: WileyVol: 25Issue #: 7Start Page: 837End Page: 858Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/cns.13141Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.13141Citation Count: 41
- Somatosensory-motor cortex interactions measured using dual-site transcranial magnetic stimulation2019RESTRICTEDTitle: Somatosensory-motor cortex interactions measured using dual-site transcranial magnetic stimulationJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 5Start Page: 1229End Page: 1243Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.04.009Citation Count: 15
- A PET study in healthy subjects of brain exposure of 11C-labelled osimertinib – A drug intended for treatment of brain metastases in non-small cell lung cancer2019OPENTitle: A PET study in healthy subjects of brain exposure of 11C-labelled osimertinib – A drug intended for treatment of brain metastases in non-small cell lung cancerJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 40Issue #: 4Start Page: 799End Page: 807Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/0271678x19843776Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/0271678X19843776Citation Count: 41
-
RESTRICTEDTitle: Selective vulnerability in α-synucleinopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 138Issue #: 5Start Page: 681End Page: 704Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-019-02010-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-019-02010-2.pdfCitation Count: 59
- Barriers and facilitators of communication about off periods in Parkinson’s disease: Qualitative analysis of patient, carepartner, and physician Interviews2019OPENTitle: Barriers and facilitators of communication about off periods in Parkinson’s disease: Qualitative analysis of patient, carepartner, and physician InterviewsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 4Start Page: e0215384End Page: e0215384Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0215384Best OA location URL: https://doi.org/10.1371/journal.pone.0215384Citation Count: 24
-
OPENTitle: Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson’s Disease PatientsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-42535-wBest OA location URL: https://www.nature.com/articles/s41598-019-42535-w.pdfCitation Count: 40
-
OPENTitle: eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the BrainJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-42261-3Best OA location URL: https://www.nature.com/articles/s41598-019-42261-3.pdfCitation Count: 2
- White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime Sleepiness2019OPENTitle: White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime SleepinessJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2019.00378Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2019.00378/pdfCitation Count: 10
- Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard2019RESTRICTEDTitle: Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide StandardJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 18Issue #: 6Start Page: 2422End Page: 2432Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00920Citation Count: 13
- Improving patient‐centred care for persons with Parkinson's: Qualitative interviews with care partners about their engagement in discussions of “off” periods2019OPENTitle: Improving patient‐centred care for persons with Parkinson's: Qualitative interviews with care partners about their engagement in discussions of “off” periodsJournal Name: Health ExpectationsPublisher: WileyVol: 22Issue #: 3Start Page: 555End Page: 564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/hex.12884Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hex.12884Citation Count: 19
-
OPENTitle: Linking vitamin B12 and a trembling disorderJournal Name: Cell ResearchPublisher: Springer Science and Business Media LLCVol: 29Issue #: 5Start Page: 343End Page: 344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41422-019-0166-3Best OA location URL: https://www.nature.com/articles/s41422-019-0166-3.pdfCitation Count: 4
- Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)2019RESTRICTEDTitle: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)2019RESTRICTEDTitle: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-011Citation Count: 0
-
-
RESTRICTEDTitle: Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-001Citation Count: 0
- Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)2019RESTRICTEDTitle: Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-010Citation Count: 1
-
OPENTitle: Defective homologous recombination DNA repair as therapeutic target in advanced chordomaJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-09633-9Best OA location URL: https://www.nature.com/articles/s41467-019-09633-9.pdfCitation Count: 69
- Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)2019RESTRICTEDTitle: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050Citation Count: 0
- Intraoperative localization of spatially and spectrally distinct resting-state networks in Parkinson’s disease2019RESTRICTEDTitle: Intraoperative localization of spatially and spectrally distinct resting-state networks in Parkinson’s diseaseJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 132Issue #: 4Start Page: 1234End Page: 1242Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3171/2018.11.jns181684Citation Count: 6
- NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)2019RESTRICTEDTitle: NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-035Citation Count: 1
-
RESTRICTEDTitle: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008Citation Count: 0
- Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)2019RESTRICTEDTitle: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-006Citation Count: 0
-
OPENTitle: Cognitive Performance in Parkinson’s Disease in the Brain Health RegistryJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 68Issue #: 3Start Page: 1029End Page: 1038Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-181009Best OA location URL: https://europepmc.org/articles/pmc6497062?pdf=renderCitation Count: 10
- Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age2019RESTRICTEDTitle: Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced ageJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-09613-zBest OA location URL: https://www.nature.com/articles/s41467-019-09613-z.pdfCitation Count: 150